Crystalline and amorphous sodium atorvastatin

Details for Australian Patent Application No. 2006281237 (hide)

Owner Arrow International Limited Zhejiang Neo-Dankong Pharmaceutical Co. Ltd

Inventors Pan, Jiangchun; Zhou, Kailan; Wang, Yunde; Liu, Hong; Hong, Huabin; Sun, Yang; Chen, Zhirong

Agent Cullen & Co

Pub. Number AU-A-2006281237

PCT Pub. Number WO2007/020421

Priority 0613567.7 07.07.06 GB; 200510060395.5 15.08.05 CN

Filing date 14 August 2006

Wipo publication date 22 February 2007

International Classifications

C07D 207/34 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/020421 Priority application(s): WO2007/020421

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006281242-Pyrazolone derivatives for the treatment of tuberculosis

2006281232-Nanoparticles